Medication info
Olesc Tablet 5/20 Milligrams

Olesc Tablet 5/20 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletOlmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Korea United Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP*3]
Approval status
Active

MFDS item code 201404972 · Approved 2014.10.27 · Insurance code 644308840

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
This drug is administered as 1 tablet once daily with water, with or without food. It is recommended that it be taken at the same time every day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil) before treatment with this drug. However, a direct switch to this drug may be considered if blood pressure is not controlled with monotherapy using the individual components. The maximum dose of this drug is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of 2 weeks or longer, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams as monotherapy. - 10/20 milligrams: Administer to patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams as monotherapy. - 5/40 milligrams: Administer to patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: Administer to patients whose blood pressure is not adequately controlled with 5/40 milligrams. ○Patients with renal impairment: This drug has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil in patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily, and administration of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients on dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ○Patients with reduced effective intravascular volume: In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose with close monitoring of their condition. ○Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. In patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics, blood pressure and renal function should be closely monitored. Do not administer this drug to patients with severe hepatic impairment. (See section 2, “Patients in whom this drug must not be administered,” under Precautions for Use.) ○Elderly patients: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in elderly patients.
Child dose
○Pediatric patients: Safety and efficacy have not been established in pediatric patients under 18 years of age.

Ingredients

Manufacturer
Korea United Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used to treat essential hypertension in patients whose blood pressure is not adequately controlled by monotherapy with amlodipine or olmesartan medoxomil. It effectively lowers blood pressure and reduces the burden on blood vessels and the heart. Through effective management of hypertension, the risk of serious complications such as stroke and myocardial infarction can be reduced. Patients should ensure treatment effectiveness through regular doses and regular blood pressure monitoring. For safe use, it is important to strictly follow the doctor's instructions. This medication is effectively used to treat essential hypertension.

How to take

Adult dose

This drug is administered as 1 tablet once daily with water, with or without food. It is recommended that it be taken at the same time every day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil) before treatment with this drug. However, a direct switch to this drug may be considered if blood pressure is not controlled with monotherapy using the individual components. The maximum dose of this drug is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of 2 weeks or longer, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams as monotherapy. - 10/20 milligrams: Administer to patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams as monotherapy. - 5/40 milligrams: Administer to patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: Administer to patients whose blood pressure is not adequately controlled with 5/40 milligrams. ○Patients with renal impairment: This drug has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil in patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily, and administration of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients on dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ○Patients with reduced effective intravascular volume: In patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose with close monitoring of their condition. ○Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil in patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. In patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics, blood pressure and renal function should be closely monitored. Do not administer this drug to patients with severe hepatic impairment. (See section 2, “Patients in whom this drug must not be administered,” under Precautions for Use.) ○Elderly patients: In general, initiate treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in elderly patients.

Child dose

○Pediatric patients: Safety and efficacy have not been established in pediatric patients under 18 years of age.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used in cases of hypersensitivity to its active ingredients, during pregnancy or breastfeeding, in patients with severe liver impairment or aortic stenosis, in patients with biliary obstruction, patients undergoing renal dialysis, patients in shock, and certain diabetic patients. Patients with low blood pressure due to fluid or electrolyte depletion may experience initial hypotensive symptoms, so careful monitoring is required during administration. Rapid expansion of blood vessels may lead to hypotension, thus it should be used cautiously in patients with severe aortic stenosis, obstructive coronary artery disease, or congestive heart failure. Patients with impaired kidney function are at risk of worsening kidney function, so caution is needed. In patients with reduced liver function, since this medication is metabolized in the liver, dose adjustments and caution are necessary. During the use of this medication, side effects such as dizziness, headache, hypotension, nausea, rash, swelling may occur, and if symptoms are severe, it is important to consult a doctor. Particularly during pregnancy, this medication can cause serious harm to the fetus, therefore, if pregnancy is planned or occurs, it is essential to discuss with a doctor. During breastfeeding, since this medication may pass into breast milk and cause adverse reactions in infants, it is recommended to either cease breastfeeding or discontinue the medication. It is not recommended for children under 18 years of age as safety and effectiveness have not been established. In the elderly, as kidney and liver function may be reduced, dosing should start at a low dose and be adjusted carefully. In case of overdose, hypotension and heart dysfunction may occur, and immediate medical attention should be sought for proper treatment. This medication should be stored away from direct sunlight and moisture, and out of reach of children.

Side effects

  • Drug hypersensitivity
  • hyperkalemia
  • decreased libido
  • dizziness
  • headache
  • orthostatic hypotension
  • drowsiness
  • paresthesia
  • sensory loss
  • syncope
Show 78 more
  • vertigo
  • palpitations
  • rapid heartbeat
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • nausea
  • vomiting
  • dyspepsia
  • diarrhea
  • constipation
  • dry mouth
  • upper abdominal pain
  • rash
  • urticaria
  • muscle tension
  • limb pain
  • low back pain
  • polyuria
  • erectile dysfunction
  • peripheral edema
  • edema
  • pitting edema
  • fatigue
  • asthenia
  • facial edema
  • decreased blood potassium
  • increased serum creatinine
  • increased uric acid
  • elevated gamma-glutamyl transferase
  • decreased hemoglobin and hematocrit
  • cholelithiasis
  • female breast neoplasm
  • exacerbation of cerebral infarction
  • gum bleeding
  • chest pain
  • cold
  • increased CRP
  • fever
  • hemoptysis
  • excessive sneezing
  • runny nose
  • laryngitis
  • arthritis
  • flank pain
  • generalized pain
  • hypoglycemia
  • weight loss
  • heartburn
  • gastroenteritis
  • shingles
  • insomnia
  • asthenia
  • angioedema
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • acute kidney failure
  • hair loss
  • itching
  • autoimmune hepatitis
  • elevated serum creatinine
  • hyperkalemia
  • flushing
  • fatigue
  • edema
  • palpitations
  • drowsiness
  • abdominal pain
  • jaundice
  • elevated liver enzymes
  • leukopenia
  • thrombocytopenia
  • toxic epidermal necrolysis
  • hypotension
  • tachycardia
  • non-cardiogenic pulmonary edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is best to keep it at a temperature between 1 and 30 degrees Celsius, which is the normal room temperature.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP*3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.